TWO SIGMA INVESTMENTS, LP - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 50 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$274,000
+158.5%
265,850
+202.3%
0.00%
Q2 2021$106,000
-74.0%
87,950
-71.9%
0.00%
-100.0%
Q1 2021$407,000
+3.8%
313,251
+193.0%
0.00%0.0%
Q4 2020$392,000
+734.0%
106,924
+563.8%
0.00%
Q3 2019$47,000
-89.0%
16,109
-90.4%
0.00%
-100.0%
Q1 2019$427,000
+23.8%
167,318
+34.3%
0.00%0.0%
Q4 2018$345,000
+167.4%
124,606
+758.4%
0.00%
Q3 2018$129,00014,5160.00%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Broadfin Capital, LLC 629,340$5,607,0000.82%
Baker Brothers Advisors 4,833,897$43,070,0000.28%
Kassirer Asset Management Corp 19,341$172,0000.11%
Virtus ETF Advisers LLC 34,596$308,0000.03%
Palo Alto Investors LP 77,044$686,0000.03%
ROPES WEALTH ADVISORS LLC 12,500$111,0000.03%
OXFORD ASSET MANAGEMENT LLP 147,560$1,280,0000.03%
Candriam S.C.A. 195,000$1,737,0000.02%
NATIXIS 429,816$3,830,0000.02%
Cordasco Financial Network 1,875$17,0000.02%
View complete list of IDERA PHARMACEUTICALS INC shareholders